ENDO PHARMACEUTICALS HLDGS - 29264F205
Sector:
No information yet
· Industry:
No information yet
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2014
· Q4 2013
Value (USD)
Total reported value ($000)
$72.69M
QoQ value delta ($000)
-$8.528B
(-99.15%)
Implied price effect (QoQ)
+12.99%
Shares
Total shares
1,058,872
QoQ shares delta
-140,510,362
(-99.25%)
Total shares held by funds (by quarter)
Top holders (Q1 2014)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Tiger Legatus Capital Management, LLC | 26,430 | 385,000 | 10.59% |
| LMR Partners LLP | 24,834 | 361,752 | 3.48% |
| Greenwich Wealth Management LLC | 15,288 | 222,700 | 1.06% |
| GAMBLE JONES INVESTMENT COUNSEL | 4,266 | 62,148 | 0.5% |
| NCM Capital Advisers, Inc. | 738 | 10,750 | 1.16% |
| MONETA GROUP INVESTMENT ADVISORS LLC | 504 | 7,340 | 0.3% |
| RUSSELL FRANK CO/ | 318 | 4,633 | 0.0% |
| BBVA COMPASS BANCSHARES, INC | 285 | 4,150 | 0.01% |
| Gemmer Asset Management LLC | 17 | 244 | 0.01% |
| COLONY GROUP LLC | 11 | 155 | 0.0% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | 0 | 0.0% |